Aurora Cannabis Inc. (NASDAQ: ACB) is seeing a significant increase in trading value of 22.30%, with a most recent check of $5.27. The recent passing of the German Cannabis Act and the current increase in the price of ACB’s shares on the US stock exchange are related.
With the formal implementation of the Cannabis Act, Aurora Cannabis (ACB) has accepted the German government’s final approval of cannabis legalization, which represents a major step forward in enhancing patient access to medicinal cannabis.
This legislative modification is a long-overdue reform intended to promote greater accessibility to the medicinal cannabis industry and show a strong dedication to patients. It establishes a standard for international growth attempts and is consistent with the progressive policies of leading nations like Canada.
Aurora Cannabis has always supported a more liberal approach to cannabis, and Germany’s reform initiatives have significantly improved patient access to medicinal marijuana. Aurora Cannabis, a leader in the industry, has consistently upheld patient welfare.
It will strengthen Aurora Cannabis’ commitment to patient outreach and ensure widespread access to premium medical cannabis since cannabis is no longer considered a narcotic, which will enable more patients to get treatment. By improving accessibility, Aurora Cannabis demonstrates its commitment to promoting positive change in the cannabis industry.
Aurora Cannabis, one of the country’s top suppliers of medicinal cannabis, can fortify its stronghold on the market with these developments, along with the cultural significance of cannabis legalization in Germany.
Cannabis’s reclassification as a non-narcotic drug is expected to encourage more patients to discuss its medicinal benefits with their doctors, creating more access, understanding, and knowledge of its benefits.
Parallel to this, Aurora Cannabis recently received approval for its Canadian manufacturing facilities, River and Ridge, under the Good Manufacturing Practices (GMP) program from the Therapeutic Goods Administration (TGA) of Australia. The TGA is in charge of overseeing the manufacture, distribution, import, export, and promotion of medicinal products inside Australia.
